OLMESARTAN MEDOXOMIL

Product NDC
50090-7979
11-digit product format
500907979
Labeler code
50090
Product ID
50090-7979_4fce0ea5-232e-4894-a2ee-3c9bb28149b0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
olmesartan medoxomil
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA206720
Marketing category
ANDA
Marketing start
2022-03-04
Substance
OLMESARTAN MEDOXOMIL
Active strength
40 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A206720-001OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02
A206720-002OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-02
A206720-003OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A206720-001AB
A206720-002AB
A206720-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-0284e616aacf4f…
2026-09-14 22:38:342026-08A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-0284e616aacf4f…
2026-09-14 22:38:342026-08A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-0284e616aacf4f…
2026-08-18 06:07:402026-07A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02caaa826d4ba7…
2026-08-18 06:07:402026-07A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-02caaa826d4ba7…
2026-08-18 06:07:402026-07A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-02fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-02b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-0203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-0203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-022680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-022680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-025bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-025bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-02d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02d06236e962d9…
2024-10-29 15:01 UTC2024-10A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-02d06236e962d9…
2024-10-29 15:01 UTC2024-10A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-0279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206720-002OLMESARTAN MEDOXOMIL20MGTABLET / ORALAB2022-12-0279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206720-003OLMESARTAN MEDOXOMIL40MGTABLET / ORALAB2022-12-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206720-001OLMESARTAN MEDOXOMIL5MGTABLET / ORALAB2022-12-02301d65b070ca…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A206720-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A206720-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A206720-003AB184e616aacf4f…
2026-08-18 06:07:402026-07A206720-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A206720-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A206720-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206720-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206720-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A206720-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206720-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206720-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206720-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A206720-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206720-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A206720-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206720-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206720-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206720-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206720-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206720-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206720-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206720-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206720-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206720-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206720-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206720-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206720-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206720-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206720-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206720-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206720-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206720-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206720-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206720-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A206720-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A206720-003AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206720-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206720-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206720-003AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206720-001AB1301d65b070ca…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
OLMESARTAN MEDOXOMIL
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OLMESARTAN MEDOXOMIL40 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6M97XTV3HDInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
349405Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4bf142a3-ad7f-4ed5-98c2-54d8509b7dbcAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1Product name320260303
96816964-c075-ffa7-b7b8-d8570411a3b9Product name720250305
caadbc51-b731-1a7b-b91a-f7bb4a62554eProduct name920240306
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
4a27501f-a987-48a5-99b4-e983d4744d76Product name720181211
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMILA-S Medication Solutions4bf142a3-ad7f-4ed5-98c2-54d8509b7dbc2026-05-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206720
application number: ANDA206720
ndc (product): 50090-7979
OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMILA-S Medication Solutions7f78d14a-acf2-4f82-9d20-dfcbd5e9ffb32026-05-29Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206720
application number: ANDA206720
OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMILBryant Ranch Prepack2bb63404-7d54-4482-8377-6ff02052892a2026-03-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206720
application number: ANDA206720
Olmesartan MedoxomilOLMESARTAN MEDOXOMILDirect_rx1ba299e7-0651-c23b-e063-6294a90a02452025-01-28Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206720
application number: ANDA206720
OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMILBryant Ranch Prepack879630ff-662a-40bd-b74f-a864661dea952024-06-13Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206720
application number: ANDA206720
OLMESARTAN MEDOXOMILOLMESARTAN MEDOXOMILSolco Healthcare US, LLC.6e602f81-1cc3-4ae1-8bdf-85572e35cf732022-03-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206720
application number: ANDA206720

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
50090-7979-05009079790030 TABLET in 1 BOTTLE (50090-7979-0) 30 tablet2026-05-27NoNoCurrent
50090-7979-15009079790190 TABLET in 1 BOTTLE (50090-7979-1) 90 tablet2026-05-27NoNoCurrent